Search

everythinglearnresearchcommunity

for

Search:↓

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Enhancing immune response can improve cancer treatment effectiveness.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Bullous pemphigoid can look like erythema multiforme, so awareness is needed for proper treatment.

Immunoadsorption successfully treated a man's resistant polymyositis.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.